HHRI News & Press Releases
September 22, 2026 -- A transition is underway in the management of the nation's transplant data infrastructure. Publicis Sapient, a global digital business transformation company, is in the process of taking over fundamental elements of the Scientific Registry of Transplant Recipients (SRTR) contract, from the Hennepin Healthcare Research Institute (HHRI). The transition is currently in progress. The IT infrastructure transition is expected to be fully completed by December 1, 2026, with other contract element timelines yet to be determined.
SRTR is a vital national resource that supports the transplant community through comprehensive data analysis, with a core mission of improving patient outcomes and experience. It operates under a contract from the Division of Transplantation (DoT), Health Systems Bureau (HSB), Health Resources and Services Administration (HRSA), U.S. Department of Health and Human Services (HHS). The registry provides program-specific reports on transplant programs and organ procurement organizations, offering wide-ranging information to clinicians, researchers, and patients.
HHRI has been a cornerstone of medical research since 1952, supporting and overseeing research conducted at HCMC, the flagship acute care and teaching hospital of the Hennepin Healthcare System in downtown Minneapolis. As one of the largest medical research nonprofits in Minnesota, HHRI often ranks in the top ten percent nationally of institutions receiving research grants from the National Institutes of Health (NIH). The organization, through its Chronic Disease Research Group (CDRG), has operated SRTR for over 15 years with a steadfast commitment to its mission of transforming health and health care for all through ethical research and meaningful community partnerships.
The transition from HHRI to Publicis Sapient is being conducted collaboratively to ensure a seamless transfer of responsibilities and the continued integrity of SRTR's operations. Both organizations are dedicated to ensuring that the registry continues to provide reliable, data-driven insights that are essential for the transplant community and the patients they serve.
Further updates will be provided as the transition progresses.
More HHRI Research Highlights
Dr. Fred Apple to lecture, conduct research in Spain
Hennepin Healthcare Research Institute (HHRI) investigator Fred Apple, PhD, DABCC, has been invited to be a Visiting Professor and Lecturer at Sant Pau Hospital De La Santa Creu, Universitat Autonoma de Barcelona (Spain) for the first Trimester of 2019. His host will be Jordi Ordonez-Llanos, MD, PhD, Senior Consultant, Hospital…
Read More
Study: Rise in meth and opioid use during pregnancy
Usage rates among moms-to-be have spiked in the past decade, with a disparate boost among pregnant women who live in rural counties. Amphetamine and opioid use in pregnancy increased substantially over the last decade in the United States, a new Michigan Medicine-led study finds. And a disproportionate rise occurred in…
Read More
Dr. Marco Pravetoni discusses opioid vaccine research on MPR
An estimated 30,000 people died from opioid overdoses in the U.S. in 2017. With so many people being affected what is being done to treat addiction? Marco Pravetoni, PhD, senior investigator at the Hennepin Healthcare Research Institute and associate professor in the Department of Pharmacology at the University of Minnesota…
Read More
Amphetamine-related hospitalizations surge between 2003 and 2015
An analysis conducted by Hennepin Healthcare, University of Minnesota School of Public Health and University of Michigan researchers shows amphetamine-related hospitalizations increased more than 270 percent from 2008 to 2015, costing up to $2.17 billion per year. The study was recently published in JAMA Network Open. “It’s worrying,” said Associate Professor and co-author Nathan Shippee.…
Read More
Daily low-dose aspirin found to have no effect on healthy life span in older people
Large NIH-funded study examined outcomes in United States and Australia. In a large clinical trial to determine the risks and benefits of daily low-dose aspirin in healthy older adults without previous cardiovascular events, aspirin did not prolong healthy, independent living (life free of dementia or persistent physical disability). Risk of…
Read More
How is opioid use associated with health, other substance use, involvement in criminal justice system?
A public health approach to address the opioid epidemic in the United States needs to understand the populations of people affected, including their health, other substance use and any involvement they may have with the criminal justice system, according to a new study published in JAMA Network Open. This study…
Read More
Study shows integrated care affects health care use among vulnerable adults
Two studies published this week in Medical Care Research & Review found that providing integrated medical care and social support services led to increased use of primary care among very low-income adults in Hennepin County, Minn., who were enrolled in a Medicaid accountable care organization (ACO) between 2012 and 2014.…
Read More